Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q2 2024 Earnings

7MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.63

-0.56

-0.49

-0.42

Details

Expected EPS

-0.484

Actual EPS

-0.42

Surprise EPS

0.06

Surprise Percent

+13.22%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.42 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.